Estados Unidos · Plataformas y datos · Yahoo Finance

Bristol Myers (BMY) Has New Cancer Wins. Can They Offset the Patent Cliff?

Publicado por Yahoo Finance · Estados Unidos hace 10 h

Drug Problem Bristol-Myers Squibb Company (NYSE:BMY) reported positive data from its radiopharmaceutical RYZ101 Phase III ACTION-1 trial and additional progress across multiple…

Leer el artículo completo en Yahoo Finance Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (finance.yahoo.com)

Bristol Myers (BMY) Has New Cancer Wins. Can They Offset the Patent Cliff?

También te puede interesar

Alcoa (NYSE:AA) Stock Gets Price Target Trim from Citigroup

Equifax: 3 Key Takeaways for Long-Term Investors

One consortium moves ahead in the GFL Environmental sales process - CTFN (update)

Here’s what matters most to Tesla investors heading into earnings

US Tiger Securities reiterates buy on Coinbase stock, cites Bitcoin rebound

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Bristol Myers (BMY) Has New Cancer Wins. Can They Offset the Patent Cliff?

Compartir

También te puede interesar

Alcoa (NYSE:AA) Stock Gets Price Target Trim from Citigroup

Equifax: 3 Key Takeaways for Long-Term Investors

One consortium moves ahead in the GFL Environmental sales process - CTFN (update)

Here’s what matters most to Tesla investors heading into earnings

US Tiger Securities reiterates buy on Coinbase stock, cites Bitcoin rebound

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030